» Articles » PMID: 3821931

Inhibition by K+ of Uptake2 of 3H-(+/-)-isoprenaline in the Perfused Rat Heart

Overview
Specialty Pharmacology
Date 1986 Dec 1
PMID 3821931
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The kinetics of the inhibitory effect of extracellular K+ on uptake2 of 3H-(+/-)-isoprenaline were determined in isolated hearts obtained from reserpine-pretreated rats; catechol-O-methyl transferase was inhibited. Initial rates of uptake2 of a very low concentration of 3H-(+/-)-isoprenaline (10 nmol/l) were determined in the presence of various extracellular concentrations of K+ (2.7 to 60 mmol/l). The inhibitory effect of K+ was concentration-dependent with an IC50 of about 20 mmol/l. - In these experiments KCl was added to the perfusion solution, and some hypertonicity resulted. In some experiments NaCl was added to a solution containing 5 mmol/l K+ to result in the same degree of hypertonicity as that obtained for 60 mmol/l K+; hypertonicity increased the initial rate of uptake2 of 3H-(+/-)-isoprenaline. Thus, the inhibitory effect of K+ had been slightly underestimated. In subsequent experiments the increase of the concentration of K+ in the perfusion fluid to 30 mmol/l was compensated for by a corresponding reduction of Na+. Initial rates of uptake2 of 10 nmol/l 3H-(+/-)-isoprenaline were determined in the absence and presence of various concentrations of unlabelled (+/-)-isoprenaline. At 30 mmol/l K+ the IC50 (= Km for uptake2) did not significantly differ from that determined in an earlier study at 2.7 mmol/l K+ (Grohmann and Trendelenburg 1984). Finally, the Vmax for uptake2 of 3H-(+/-)-isoprenaline was determined at either 2.7 or 30 mmol/l K+. At 30 mmol/l K+ the Vmax was only about 1/4 of that observed at 2.7 mmol/l K+.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The acceleration of the extraneuronal efflux of 3H-(+/-)-isoprenaline induced by high extracellular potassium.

Grohmann M Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(4):406-7.

PMID: 3405316 DOI: 10.1007/BF00169531.


The uptake and O-methylation of 3H-(+/-)-isoprenaline in rat cerebral cortex slices.

Wilson V, Grohmann M, Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(4):397-405.

PMID: 3405315 DOI: 10.1007/BF00169530.


The membrane potential of vascular smooth muscle appears to modulate uptake2 of 3H-isoprenaline.

Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(1):33-6.

PMID: 2888025 DOI: 10.1007/BF00177748.


The force driving the extraneuronal transport mechanism for catecholamines (uptake2).

Schomig E, Babin-Ebell J, Russ H, Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol. 1992; 345(4):437-43.

PMID: 1620244 DOI: 10.1007/BF00176622.


Evidence from guinea-pig trachealis that Uptake2 of isoprenaline is enhanced by hyperpolarization of the smooth muscle.

Bryan-Lluka L, Vuocolo H Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(4):399-404.

PMID: 1359431 DOI: 10.1007/BF00171081.

References
1.
Trendelenburg U . Modulation of uptake2 of 3H-(+/-)-isoprenaline by isoprenaline-induced depolarization of rat salivary gland cells. Naunyn Schmiedebergs Arch Pharmacol. 1986; 334(4):388-92. DOI: 10.1007/BF00569375. View

2.
Azevedo I, Bonisch H, Osswald W, Trendelenburg U . Autoradiographic study of rat hearts perfused with 3H-isoprenaline. Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(1):1-5. DOI: 10.1007/BF00649345. View

3.
Sammet S, Graefe K . Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for CO-transport. Naunyn Schmiedebergs Arch Pharmacol. 1979; 309(2):99-107. DOI: 10.1007/BF00501216. View

4.
Gillespie J, Towart R . Uptake kinetics and ion requirements for extraneuronal uptake of noradrenaline by arterial smooth muscle and collagen. Br J Pharmacol. 1973; 47(3):556-67. PMC: 1776356. DOI: 10.1111/j.1476-5381.1973.tb08186.x. View

5.
Major H, Sauerwein I, Graefe K . Kinetics of the uptake and metabolism of 3H-(+/-) isoprenaline in the rat submaxillary gland. Naunyn Schmiedebergs Arch Pharmacol. 1978; 305(1):51-63. DOI: 10.1007/BF00497006. View